Cannabinoids as neuroprotective agents in traumatic brain injury

被引:30
作者
Biegon, A [1 ]
机构
[1] Lawrence Berkeley Natl Lab, Dept Funct Imaging, Berkeley, CA USA
关键词
head injury; cannabimimetics; marilulana products; cridocarinabinoids; cannabinoid receptors; antioxidants;
D O I
10.2174/1381612043384196
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The name "Cannabinoid" applies to a large and diverse family of compounds including plant derived, synthetic and endogenously produced chemicals. Some but not all of which are psychotropic. Cannabinoids of all classes have the ability to protect neurons from a variety of insults that are believed to underlie delayed neuronal death after traumatic brain in (TBI), including excitotixicity, calcium influx free radical formation and neuroinflamination. Thc pathways and experimental models supporting a neuroprotective role the the various classes of cannabinoids are critically reviewed vis a vis their potential to support the development of a clinically viable nueroprotective agent for human TBI.
引用
收藏
页码:2177 / 2183
页数:7
相关论文
共 101 条
[1]  
Abel EL., 1980, MARIHUANA 1 12000 YE
[2]   Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis [J].
Achiron, A ;
Miron, S ;
Lavie, V ;
Margalit, R ;
Biegon, A .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 102 (01) :26-31
[3]  
Adams IB, 1998, J PHARMACOL EXP THER, V284, P1209
[4]  
Arévalo-Martin A, 2003, J NEUROSCI, V23, P2511
[5]   Cannabinoid receptors and their endogenous agonist, anandamide [J].
Axelrod, J ;
Felder, CC .
NEUROCHEMICAL RESEARCH, 1998, 23 (05) :575-581
[6]   Cannabinoids control spasticity and tremor in a multiple sclerosis model [J].
Baker, D ;
Pryce, G ;
Croxford, JL ;
Brown, P ;
Pertwee, RG ;
Huffman, JW ;
Layward, L .
NATURE, 2000, 404 (6773) :84-87
[7]   NEUROPROTECTIVE ACTIVITY OF HU-211, A NOVEL NMDA ANTAGONIST, IN GLOBAL-ISCHEMIA IN GERBILS [J].
BARJOSEPH, A ;
BERKOVITCH, Y ;
ADAMCHIK, J ;
BIEGON, A .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1994, 23 (2-3) :125-135
[8]   A novel nonpsychotropic cannabinoid, HU-211, in the treatment of experimental pneumococcal meningitis [J].
Bass, R ;
Engelhard, D ;
Trembovler, V ;
Shohami, E .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03) :735-738
[9]   HU-211, A NONPSYCHOTROPIC CANNABINOID, IMPROVES NEUROLOGICAL SIGNS AND REDUCES BRAIN-DAMAGE AFTER SEVERE FOREBRAIN ISCHEMIA IN RATS [J].
BELAYEV, L ;
BARJOSEPH, A ;
ADAMCHIK, J ;
BIEGON, A .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, 25 (01) :19-33
[10]   HU-211, A NOVEL NONCOMPETITIVE N-METHYL-D-ASPARTATE ANTAGONIST, IMPROVES NEUROLOGICAL DEFICIT AND REDUCES INFARCT VOLUME AFTER REVERSIBLE FOCAL CEREBRAL-ISCHEMIA IN THE RAT [J].
BELAYEV, L ;
BUSTO, R ;
ZHAO, WZ ;
GINSBERG, MD .
STROKE, 1995, 26 (12) :2313-2319